摘要
目的：探讨老年冠心病介入治疗过程中应用替罗非班的临床效果并进行分析。方法：我院于2011年1月-2012年6月收治的152例老年冠心病患者,分为两组。其中76例老年冠心病患者在行介入过程中给予替罗非班,作为观察组,其余患者作为对照组。对比两组无复流、胸痛、再次血运重建的发生情况。结果：观察组3例无复流,8例胸痛,2例再次血运重建；对照组中14例无复流,24例胸痛,10例再次血运重建。结论：通过在介入过程中应用替罗非班治疗老年冠心病,可有效减少无复流高危病变患者的无复流以及相关缺血性心脏事件发生,其临床效果显著,值得推广。
Objective： Explore elderly coronary intervention in the course of treatment, the application of the clinical effect of tirofiban and analysis. Methods：I admitted to the hospital in January 2011-2012 in June of 152 elderly patients with coronary heart disease patients, divided into two groups. Given tirofiban group, as observed in which 76 elderly patients with coronary heart disease patients undergoing intervention process;remaining patients as a control group. Comparing two sets of no-reflow, chest pain, the incidence of repeat revascularization. Results：Three cases of no-reflow observation group, eight cases of chest pain, two cases of repeat revascularization;14 cases in the control group, no-reflow, 24 cases of chest pain, 10 cases of repeat revascularization. Conclusion：By application tirofiban treatment of elderly patients with coronary heart disease, which can effectively reduce no-reflow in patients with high-risk lesions of no-reflow and ischemic cardiac events occurred in the intervention process, the clinical effect is significant, worthy of promotion.
出处
《中国医药导刊》
2014年第4期705-706,共2页
Chinese Journal of Medicinal Guide
关键词
冠心病介入治疗
应用替罗非班
临床分析
Percutaneous coronary intervention
Application tirofiban
Clinical analysis of
